Cell-penetrating peptides with intracellular organelle targeting
- 2 August 2016
- journal article
- review article
- Published by Taylor & Francis in Expert Opinion on Drug Delivery
- Vol. 14 (2) , 245-255
Abstract
Introduction: One of the major limiting steps in order to have an effective drug is the passage through one or more cell membranes to reach its site of action. To reach the action-site, the specific macromolecules are required to be delivered specifically to the cell compartment/organelle in their (pre)active form. Areas covered: In this review, we will discuss cell-penetrating peptides (CPPs) developed in the last decade to transport small RNA/DNA, plasmids, antibodies, and nanoparticles into specific sites of the cell. The article describes CPPs in complex with cargo molecules that target specific intracellular organelles and their potential for pharmacological or clinical use. Expert opinion: Organelle targeting is the ultimate goal to ensure selective delivery to the site of action in the cells. CPP technologies represent an important strategy to address drug delivery to specific intracellular compartments by covalent conjugation to targeting sequences, potentially enabling strategies to combat genomic diseases as well as infections, cancer, neurodegenerative and hereditary diseases. They have proven to be successful in delivering various therapeutic agents into cells however, further in vivo experiments and clinical trials are required to demonstrate the efficacy of this technology.Keywords
Funding Information
- European Regional Development Fund (Centre of Excellence of Chemical Biology (3.2.0101, Tumor-Tech (3.2.1001.11-0008))
- Swedish Research Council for Medical Research (K2012-66X-21148-04-5)
- Swedish Research Council for Natural Sciences (621-2011-5902)
- Swedish Cancer Society (CAN 2012/251)
- Estonian Science Foundation (ETF9438)
- Estonian Ministry of Education and Research (IUT2-22, IUT20–26)
This publication has 96 references indexed in Scilit:
- Spontaneous Membrane-Translocating Peptides by Orthogonal High-Throughput ScreeningJournal of the American Chemical Society, 2011
- Ribosome defects in disorders of erythropoiesisInternational Journal of Hematology, 2011
- Design of a peptide-based vector, PepFect6, for efficient delivery of siRNA in cell culture and systemically in vivoNucleic Acids Research, 2011
- Chondroitin Sulfate as a Molecular Portal That Preferentially Mediates the Apoptotic Killing of Tumor Cells by Penetratin-directed Mitochondria-disrupting PeptidesJournal of Biological Chemistry, 2010
- Characterization and prediction of protein nucleolar localization sequencesNucleic Acids Research, 2010
- ER–Golgi network—A future target for anti-cancer therapyLeukemia Research, 2009
- Enhanced cytotoxicity of TATp-bearing paclitaxel-loaded micelles in vitro and in vivoInternational Journal of Pharmaceutics, 2009
- Targeting cyclin B1 through peptide-based delivery of siRNA prevents tumour growthNucleic Acids Research, 2009
- Nuclear Localization of Cell-Penetrating Peptides Is Dependent on Endocytosis Rather Than Cytosolic Delivery in CHO CellsMolecular Pharmaceutics, 2009
- A New Potent Secondary Amphipathic Cell–penetrating Peptide for siRNA Delivery Into Mammalian CellsMolecular Therapy, 2009